Early Wednesday, AbbVie stock rose after the pharmaceutical company reported adjusted profit of $2.92 per share on $13.86 billion in sales for its fourth quarter.
On average, analysts polled by FactSet expected AbbVie (ABBV) to earn $2.85 per share, on an adjusted basis, and to report nearly $13.7 billion in sales.
In the year-earlier period, AbbVie earnings were $2.21 a share on $8.7 billion in sales.
For the year ending in 2021, AbbVie guided to EPS of $12.32-$12.52. The Street expected AbbVie earnings of $12.20 per share and $54 billion in sales.
https://www.investors.com/news/technology/abbvie-stock-abbvie-earnings-q4-2020/
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.